NCT02456883
- Conditions
- Advanced Solid Tumors, Pharmacokinetics of 14C-labeled Gilteritinib
- Locations
-
- Site US10001 Cleveland, Ohio, United States
Clinical trial condition
Explore clinical trials studying Pharmacokinetics of 14C-labeled Gilteritinib. Study availability and eligibility vary by location and protocol.
NCT02456883